D-2570
- Generic Name
- D-2570
Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- InventisBio Co., Ltd
- Target Recruit Count
- 161
- Registration Number
- NCT06278350
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath